Cytokines in mice treated with amphotericin B-intralipid

References

• Shadkchan Y, Segal E, Bor A, Gov Y, Rubin M, Lichtenberg D. The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures. J Antimicrob Chemother 1997; 39: 655–658.
   PubMed Web of Science ®Google Scholar
• Shadkchan Y, Segal E. Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naïve mice. J Ant imicrob Chemother 1999; 44: 787–790.
   PubMed Web of Science ®Google Scholar
• Shadkchan Y, Segal E. Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice. J Antimicrob Chemother 2001; 48: 245–251.
   PubMed Web of Science ®Google Scholar
• Shadkchan Y, Zaslavslcy Z, Segal E. Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid. Med Mycol 2002; 41: 15–19.
   Google Scholar
• Benson JM, Nahata MC. Clinical use of systemic antifungal agents. Clin Pharmacol 1988; 7: 424–38.
   PubMedGoogle Scholar
• Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphoter-icin B. Current understanding of mechanism of action. Ant imicrob Agents Chemother 1990; 34: 183–188.
   PubMed Web of Science ®Google Scholar
• Gallis HA. Amphotericin B: a commentary on its role as an antifungal agent and as a comparative agent in clinical trials. Clin Infect Dis 1996; 22: s145–147.
   Web of Science ®Google Scholar
• Barton CH, Pahl M, Vaziri ND, Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am J Med 1984; 77: 471–74.
   PubMed Web of Science ®Google Scholar
• Vonk AG, Netea MG, Denecker N, Verschuueren I, van der Meer J, Kullberg BJ. Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J Antimicrob Chemother 1998; 42: 469–474.
   Google Scholar
• Aming M, Kliche KO, Heer-Sonderhoff AH, Wehmeier A. Infusion-related toxicity of three different amphotericin B for-mulations and its relation to cytokine plasma levels. Mycoses 1995; 38: 459–465.
   Google Scholar
• Benedict S, Colagreco J. Fungal infections associated with malignancies, treatments and AIDS. Cane Nurs 1994; 17: 411–7.
   Google Scholar
• Bodey GP, MA Luna. Disseminated candidiasis in patients with acute leukemia. Clin Infect Dis 1998; 27: 238.
   PubMed Web of Science ®Google Scholar
• Borzotta AP, K Beardsley. Candida infections in critically ill trauma patients. A retrospective case-control study. Arch Surg 1999; 134: 657–664.
   Google Scholar
• Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multi-center surveillance study of funguria in hospitalized patients. Clin Infect Dis 2000; 30: 14–18.
   PubMed Web of Science ®Google Scholar
• De Pauw BE, Meunier F. The challenge of invasive fungal infection. Chemotherapy 1999; 45: 1–14.
   PubMed Web of Science ®Google Scholar
• De Marie S. New development in the diagnosis and management of invasive fungal infections. Haematologica 2000; 85: 88-93. Aoun M. Standard antifungal therapy in neutropenic patients. Int J Antimicrob Agents 2000; 16: 143–145.
   Google Scholar
• Aoun M. Standard antifungal therapy in neutropenic patients. Int J Antimicrob Agents 2000; 16: 143/145. 18 Sabra R, Branch RA. Amphotericin B nephrotoxicity. Drug Safety 1990; 5: 94/108.
   Google Scholar
• Bolard J, Seignemet M, Boudet G. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Biochim Biophys Acta 1980; 599: 280/293.
   Google Scholar
• Elewski BE. Mechanism of systemic antifungal agents. J Am Acad Derm 1993; 28: 928/934.
   Web of Science ®Google Scholar
• Rogers PD, Kramer RE, Chapman SW, Cleary JD. Amphotericin B-induced interleukin-1b expression in human monocytic cells is calcium and calmodulin dependent. J Infect Dis 1999; 180: 159/ 166.
   Web of Science ®Google Scholar
• Mencacci A, Cenci E, Bacci A, Bistoni F, Romani L. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis. J Infect Dis 2000; 181: 686/694.
   Google Scholar
• Romani L. Cytokine modulation of specific and nonspecific immunity to Candida albicans. Mycoses 1999; 42: 45/48.
   Web of Science ®Google Scholar
• Chia JK, Mcmanus EJ. In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations. Antimicrob Agents Chemother 1990; 34: 906/908.
   Web of Science ®Google Scholar